Annual Short Term Debt
$0.00
-$625.00 K-100.00%
December 31, 2023
Summary
- As of February 9, 2025, SYRE annual short term debt is $0.00, with the most recent change of -$625.00 thousand (-100.00%) on December 31, 2023.
- During the last 3 years, SYRE annual short term debt has fallen by -$319.00 thousand (-100.00%).
- SYRE annual short term debt is now -100.00% below its all-time high of $625.00 thousand, reached on December 31, 2022.
Performance
SYRE Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
N/A
September 30, 2024
Summary
- SYRE quarterly short term debt is not available.
Performance
SYRE Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
SYRE Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | - |
| 3 y3 years | -100.0% | - |
| 5 y5 years | 0.0% | - |
SYRE Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | ||
| 5 y | 5-year | -100.0% | at low | ||
| alltime | all time | -100.0% | at low |
Spyre Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(-100.0%) |
| Jun 2023 | - | $4.33 M(+612.3%) |
| Mar 2023 | - | $608.00 K(-2.7%) |
| Dec 2022 | $625.00 K(+43.3%) | - |
| Dec 2022 | - | $625.00 K(+6.5%) |
| Sep 2022 | - | $587.00 K(+23.1%) |
| Jun 2022 | - | $477.00 K(+4.4%) |
| Mar 2022 | - | $457.00 K(+4.8%) |
| Dec 2021 | $436.00 K | $436.00 K(+5.1%) |
| Sep 2021 | - | $415.00 K(+0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $412.00 K(+30.8%) |
| Mar 2021 | - | $315.00 K(-1.3%) |
| Dec 2020 | $319.00 K(-9.1%) | $319.00 K(-6.5%) |
| Sep 2020 | - | $341.00 K(+49.6%) |
| Jun 2020 | - | $228.00 K(-22.2%) |
| Mar 2020 | - | $293.00 K(-16.5%) |
| Dec 2019 | $351.00 K(>+9900.0%) | $351.00 K(+21.5%) |
| Sep 2019 | - | $289.00 K(-11.9%) |
| Jun 2019 | - | $328.00 K(+3.5%) |
| Mar 2019 | - | $317.00 K(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Spyre Therapeutics annual short term debt?
- What is the all time high annual short term debt for Spyre Therapeutics?
- What is Spyre Therapeutics annual short term debt year-on-year change?
- What is the all time high quarterly short term debt for Spyre Therapeutics?
What is Spyre Therapeutics annual short term debt?
The current annual short term debt of SYRE is $0.00
What is the all time high annual short term debt for Spyre Therapeutics?
Spyre Therapeutics all-time high annual short term debt is $625.00 K
What is Spyre Therapeutics annual short term debt year-on-year change?
Over the past year, SYRE annual short term debt has changed by -$625.00 K (-100.00%)
What is the all time high quarterly short term debt for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly short term debt is $4.33 M